Rani Therapeutics Inc.
RANI | NASDAQ
$0.59
-$0.02 (-2.54%)
At close: Oct 30, 2026, 4:00 PM ET
$0.59
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 4:39 AM ET
-2.54%
(1D)No price chart data available for 1D timeframe.
Rating
55.5
+3.0 ptsFundamentals Strong
Market Sentiment Neutral
Moat None
Sector Rank #175/1028 (Top 17%)
Key Statistics
Market Data
Market Cap $38.54M
1D Range
0.57 0.61
52W Range
0.57 2.50
Valuation (TTM)
PE -2.19
PB 0.98
EV/EBITDA 0.35
Valuation (NTM)
Forward PE N/A
Forward PEG 0.04
Price Target $15.67
Cash Flow
FCF Yield -52.8%
SBC Adj. FCF Yield -76.4%
SBC Impact -44.7%
Margins
Gross Margin 96.7%
Operating Margin -675.8%
FCF Margin -417.0%
Growth (CAGR)
Revenue 3Y | 5Y 120.4% |
9.9%
Dil EPS 3Y | 5Y 57.8% |
20.7%
FCF 3Y | 5Y 39.4% |
17.4%
Returns
ROA -49.5%
ROE -129.9%
ROIC -64.0%
Financial Health
Net Cash
$49.84M
Current Ratio 5.31
Interest Coverage -28.22
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Rani Therapeutics Holdings, Inc. functions as a clinical-stage biopharmaceutical enterprise focused on revolutionizing the delivery of biologic therapies through oral administration. Its flagship inno...
Sector Healthcare
Industry Biotechnology
Employees 70
IPO Date Jul 30, 2021
Website www.ranitherapeutics.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$10.00
Upside
+1594.92%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove RANI